A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered a new molecular mechanism underlying chromosome alignment during cell ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite advances in modern medicine, survival rates remain very low, and many patients ...

In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...

Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is highly expressed in colorectal cancer (CRC) and other solid tumors, and its expression correlates with poor prognosis. CDR-609 is ...

Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...

Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...

A team of researchers at The University of Texas at Austin and the University of Porto have created a new way to target cancer—tin-based nanomaterials combined with near-infrared light. Their work has ...

Abstract: The fixed-frequency operated LLC converters can provide a fixed voltage gain with galvanic isolation between the input and output. However, when applied in two-stage AC/DC converters, the ...

A new light-driven cancer therapy uses LEDs and tin nanoflakes to kill tumors safely and affordably. Developed by teams in Texas and Portugal, it eliminates up to 92% of skin cancer cells without ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways. MIAMI, ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...